معرفی
İbrahim Halil Güngör is an Assistant Professor at Firat University in Elâzığ, Turkey, specializing in animal reproduction and artificial insemination within veterinary research. His work focuses on advancing livestock fertility through innovative semen preservation techniques.
He earned his Doctorate (Dr.) in Reproduction and Artificial Insemination from Firat University between January 2018 and September 2023. His educational background provides the foundation for his current research in reproductive biotechnology.
Güngör's research centers on animal reproduction and semen cryopreservation, with particular emphasis on mitigating oxidative stress and structural damage in sperm cells. He investigates natural compounds like sea buckthorn and sulforaphane alongside nanomaterials such as C60 fullerene to enhance sperm viability during storage and freezing. His methodology integrates advanced techniques including CASA, flow cytometry, and molecular analysis to evaluate sperm morphology, motility, and biochemical markers, contributing significantly to veterinary andrology.
Analysis of his 14 publications (2021-2025) reveals consistent innovation in ram and rabbit semen preservation. Key patterns include the application of platelet-rich plasma (PRP) and nanoparticles to counteract cryopreservation damage, alongside studies on toxin-induced testicular injury and diabetic impacts on reproductive health. His work addresses critical industry challenges in artificial insemination and livestock breeding efficiency.
No scientific awards or fellowships were documented in the provided information.
Dr. Güngör maintains active research collaborations with Firat University colleagues including Mustafa Sönmez and Seyfettin Gür, as evidenced by co-authorship across multiple studies. While specific grant funding and advising roles aren't detailed in the source material, his publication output indicates substantial research activity within the university's veterinary science ecosystem. His work operates within institutional laboratory frameworks focused on reproductive biotechnology, though specific facility details aren't disclosed in the ORCID profile.
